Top Markets
Coin of the day
Kolon TissueGene, Inc. Kolon TissueGene, Inc.

Kolon TissueGene, Inc.

950160
株式のランク #9085
Kolon TissueGene, Inc. is a biopharmaceutical firm specializing in the... Kolon TissueGene, Inc. is a biopharmaceutical firm specializing in the advancement of clinical-stage cell-based treatments for osteoarthritis. Its flagship offering is TG-C, a proprietary platform technology that integrates allogeneic primary cells with genetically engineered counterparts. Established by Kwan H. Lee on June 9, 1999, the enterprise maintains its corporate headquarters in Rockville, Maryland.
株価
$12.94
最終同期: 2026-08-28
時価総額
$1.10B
変化(1日)
-0.16%
変化(1年)
-51.50%
US
取引 Kolon TissueGene, Inc. (950160)

カテゴリー

Kolon TissueGene, Inc.(950160)の株価履歴
終値の最高値: $14.96 (2026-08-01)

終値の最安値: $50.89 (2017-11-01)
Kolon TissueGene, Inc. の株価履歴(2017 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) -2.28%
2025 232.88%
2024 144.93%
2023 -18.79%
2022 -12.44%
2019 -73.89%
2018 -22.36%
2017 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.53 -12.70%
AU
$138.18 473.58%
US
$759.27 7.20%
CH